Pandemic Perspectives
One year on from the World Health Organization declaring COVID-19 a global pandemic on 11 March 2020, editors across Informa Pharma Intelligence publications are taking a closer look at its impact and possible lasting implications for the biopharma and medtech industries.
One year on from the formal designation by the World Health Organization of the coronavirus outbreak as a pandemic, the disruptive effects on the global pharmaceutical supply chain, especially for...
For years, the pharmaceuticals industry and the generics industry in particular have become increasingly reliant on supplies of ingredients and formulations from specific geographies in Asia, notably India and China,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?